147 related articles for article (PubMed ID: 29456131)
1. High expression of CC chemokine receptor 5 (CCR5) promotes disease progression in patients with B-cell non-Hodgkin lymphomas.
Butrym A; Kryczek I; Dlubek D; Jaskula E; Lange A; Jurczyszyn A; Mazur G
Curr Probl Cancer; 2018; 42(2):268-275. PubMed ID: 29456131
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor.
Mazur G; Butrym A; Kryczek I; Dlubek D; Jaskula E; Lange A; Kuliczkowski K; Jelen M
PLoS One; 2014; 9(5):e98194. PubMed ID: 24859274
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory chemokine gene expression influences survival of patients with non-Hodgkin's lymphoma.
Mazur G; Jaskuła E; Kryczek I; Dłubek D; Butrym A; Wróbel T; Lange A; Kuliczkowski K
Folia Histochem Cytobiol; 2011; 49(2):240-7. PubMed ID: 21744323
[TBL] [Abstract][Full Text] [Related]
4. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
[No Abstract] [Full Text] [Related]
5. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
[TBL] [Abstract][Full Text] [Related]
6. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
7. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
8. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
[TBL] [Abstract][Full Text] [Related]
9. [Study of mutations in 5'-noncoding region of BCL-6 gene in B-cell non-Hodgkin's lymphomas].
Min DL; Zhou XY; Yang WT; Sun MH; Lu HF; Zhang TM; Zheng AH; Cao PZ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):238-41. PubMed ID: 15256116
[TBL] [Abstract][Full Text] [Related]
10. [Paraneoplastic lymphadenopathy].
Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
[TBL] [Abstract][Full Text] [Related]
11. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas.
Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA
Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688
[TBL] [Abstract][Full Text] [Related]
12. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
13. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
15. Specificity of PCR-based clonality analysis of immunoglobulin heavy chain gene rearrangements for the detection of bone marrow involvement by low-grade B-cell lymphomas.
Brinckmann R; Kaufmann O; Reinartz B; Dietel M
J Pathol; 2000 Jan; 190(1):55-60. PubMed ID: 10640992
[TBL] [Abstract][Full Text] [Related]
16. Th1/Th2 cytokine expression and its relationship with tumor growth in B cell non-Hodgkin's lymphoma (NHL).
Jones EA; Pringle JH; Angel CA; Rees RC
Leuk Lymphoma; 2002 Jun; 43(6):1313-21. PubMed ID: 12153001
[TBL] [Abstract][Full Text] [Related]
17. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of the CHFR prophase checkpoint gene in human B-cell non-Hodgkin lymphoma.
Song A; Ye J; Zhang K; Yu H; Gao Y; Wang H; Sun L; Xing X; Yang K; Zhao M
Leuk Res; 2015 May; 39(5):536-43. PubMed ID: 25798877
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Leventaki V; Guo W; Medeiros LJ; Nagarajan L
Hum Pathol; 2007 Mar; 38(3):500-7. PubMed ID: 17303500
[TBL] [Abstract][Full Text] [Related]
20. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]